https://he01.tci-thaijo.org/index.php/CMMJ-MedCMJ/issue/feedBiomedical Sciences and Clinical Medicine2026-02-06T14:58:18+07:00Pornngarm Dejkriengkraikul, PhDpornngarm.d@cmu.ac.thOpen Journal Systems<table style="height: 871px;" border="0" width="631" cellspacing="0" cellpadding="0"> <tbody> <tr> <td valign="top" width="100%"> <p><img src="https://he01.tci-thaijo.org/public/site/images/bscm_medcmu/cover-issue-18547-en-us.jpg" /></p> </td> </tr> <tr> <td valign="top" width="100%"> <h2>Welcome to the Biomedical Sciences and Clinical Medicine (BSCM)</h2> <p>It is my great pleasure to invite you to explore our journal, where we are committed to fostering inclusivity, scientific rigor, and excellence. At BSCM, our mission is to advance biomedical knowledge and clinical practice. We aim to bridge the gap between research and clinical application, ensuring that innovative discoveries translate into meaningful benefits for patients and healthcare systems worldwide. Serving as a hub for multidisciplinary collaboration, the journal brings together researchers, clinicians, and scholars from across the globe to exchange groundbreaking research and pioneering ideas that drive progress in medical science.</p> <h3>International Recognition</h3> <ul> <li class="show">Since 2022, the journal has been indexed in Scopus and is currently ranked Q4 in the subject areas of Health Professions: Pharmacy, Health Professions (miscellaneous), Medicine (miscellaneous), and Nursing (miscellaneous).</li> <li class="show">BSCM has recently been officially accepted for inclusion in the Directory of Open Access Journals (DOAJ).</li> <li class="show">All articles published from 2022 onwards are now freely accessible through the DOAJ, further enhancing the visibility and accessibility of the research we publish.</li> </ul> <h3>Looking Ahead: Important Developments Starting Issue 1, 2026</h3> <p>We are pleased to announce several important developments to better serve our authors and readers:</p> <ul> <li class="show">The number of articles per issue will increase from 9 to 15, reflecting the growth in high-quality submissions.</li> <li class="show">The Author Guidelines have been updated to require a graphical abstract.</li> <li class="show">The “Back Matters” section has been expanded from three to seven components: <ul> <li class="show">Acknowledgments</li> <li class="show">Funding</li> <li class="show">Conflicts of Interest</li> <li class="show">Author Contributions</li> <li class="show">Data Availability Statement</li> <li class="show">Institutional Review Board Statement</li> <li class="show">Informed Consent Statement</li> </ul> </li> <li class="show">Editorial workflows are being streamlined through revised Standard Operating Procedures to accelerate peer review and publication timelines.</li> </ul> <p>We warmly encourage you to consider submitting your work to BSCM. We welcome original articles, review articles, case reports, and short communications that contribute significant new insights. Please consult the updated Submission Checklist to ensure your manuscript meets our standards.</p> <p>These initiatives reflect our commitment to continuous improvement and to establishing BSCM as a trusted, internationally recognized platform for impactful biomedical and clinical research. Together, with your insights and contributions, we can continue advancing science for the benefit of global health.</p> </td> </tr> </tbody> </table>https://he01.tci-thaijo.org/index.php/CMMJ-MedCMJ/article/view/275516Association Between Polypharmacy and Frailty in Elderly Patients Receiving Care at a Public Hospital in South India2025-05-13T10:41:28+07:00Hunsur Nagendra Vishwasvishpharm@gmail.comShalini Tulasedasshalinitulasedas12@gmail.comMohana Vishnu Varadhan Sivakumarvishnumvv69@gmail.comGurulakshmi Ayyanaragurulakshmi2001@gmail.comNaveena Nagarajannavee.selva15@gmail.comBalaji Sivasubramaniamvsbalajidr@gmail.comArthi Sdrarthiarjun@gmail.comSivasankaran Ponnusankardrsponnusankar@jssuni.edu.in<p><strong>Objective</strong> This study analyses the impact of polypharmacy on frailty among the elderly patients visiting the public sector hospitals. The present study was done to assess the frailty status of the elderly patients and to see whether the individuals with polypharmacy exhibited more frailty when compared to those without polypharmacy.</p> <p><strong>Methods</strong> This is a case-control study that included 488 participants age 60 years and above who visited the general medicine department of Public Hospital Ooty, India. Polypharmacy was defined as the concomitant use of 5 or more medications. Frailty status of the participants was assessed using the Tilburg Frailty Indicator.</p> <p><strong>Results</strong> Polypharmacy was found to be present in 34.42% of cases. The prevalence of frailty was significantly higher in the polypharmacy group, affecting 41.07% of the study participants. Finally, three variables emerged as influential predictors of polypharmacy namely, 3 or more diseases (AOR 6.303, Cl 4.009-9.911, <em>p</em> < 0.0001), unsatisfied sleep status (AOR 1.669, Cl 1.068-2.606, <em>p</em> = 0.01), and people taking frailty causing drugs (AOR 4.328, Cl 2.628-7.128, <em>p</em> = 0.003). Additionally, there was a moderate relationship between modified lifestyle (smoking, alcohol consumption) and polypharmacy.</p> <p><strong>Conclusions</strong> The results suggest that polypharmacy is linked with frailty among the elderly population, highlighting the importance of clinician awareness of these factors. </p>2026-02-06T00:00:00+07:00Copyright (c) 2026 https://he01.tci-thaijo.org/index.php/CMMJ-MedCMJ/article/view/281327Prevalence of Alcohol and Drugs in Fatal Road Traffic Injuries (RTIs) in a Thai Population Between 2018 and 20232025-09-26T09:55:54+07:00Peerayuht Phuangphungpeerayuht.phu@mahidol.ac.thPatcharanun Chulamanee no@email.com<p><strong>Objective</strong> To determine and compare the prevalence of alcohol, drugs of abuse and medicines in fatal road traffic injuries (RTIs) in Thailand from 2018 through 2023.</p> <p><strong>Methods</strong> A retrospective study was conducted of fatal RTI cases sent for autopsy at the Department of Forensic Medicine, Siriraj Hospital, Mahidol University from 2018 through 2023. Subject data, including sex, age, type of RTI case, blood alcohol concentration (BAC), and urine drug profile, were collected. Descriptive statistics, Chi-square tests, Mann–Whitney U tests, and Kruskal–Wallis H tests were performed as appropriate.</p> <p><strong>Results</strong> From 2018 through 2023 a total of 1,979 fatal RTI cases were included in this study. Of those cases, 1,649 were male (83.3%) and the mean subject age was 37.3 years. The yearly prevalence of driving under the influence (DUI) of alcohol (BAC > 50 mg/dL) during the study period was between 45.80% and 53.40% with the exception of 2022, which showed a significant increase at 57.10% (<em>p</em> < 0.05). The prevalence of drugs in 2023 was 21.00%, a significant difference compared with the prevalence in 2018 of 13.70% (<em>p</em> < 0.05). The prevalence of cannabis use showed an increasing trend, with a statistically significant increase in 2023 (<em>p</em> < 0.05). The preva-lence of multiple drug use also significantly increased over the study period, particularly in 2023 (<em>p</em> < 0.05).</p> <p><strong>Conclusions</strong> The prevalence of drugs of abuse and medication in fatal RTI cases markedly increased over the study period, particularly in 2023. There was a significant increase in cannabis use and poly-drug use in fatal RTI cases over the period, especially in 2023. </p>2026-02-06T00:00:00+07:00Copyright (c) 2026 https://he01.tci-thaijo.org/index.php/CMMJ-MedCMJ/article/view/281381Biochemical and Genetic Determinants of Early Cardiovascular and Hepatic Dysfunction: A Focus on ADIPOQ Expression2025-09-23T12:19:10+07:00Rachana Raveendranarachanasharath8382@gmail.comA Josephine ajosephineanthony@gmail.comV Sureka surekaramesh.v@gmail.comP Kalaiselvi pkalaiselvi2011@gmail.comVishnu M Gvvmg4567@gmail.comSuresh Kumar K Ssureshkumarmlt43@gmail.comSimi Skariahskariahsimi@gmail.comManjusha Kmanjubivin@gmail.comSebastian J Pengiparambil sebastianjp50@yahoo.comJoby P Josejobcyjose@gmail.comRomi K Sromi.sleeba@rediffmail.comSony Peter sonypeter29@gmail.comDinesh Roy Ddrdineshroyd@gmail.com<p><strong>Objective</strong> Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease (CVD) frequently coexist due to common metabolic dysfunctions such as insulin resistance, chronic inflammation, and dyslipidemia. Adipo-nectin, encoded by the <em>ADIPOQ</em> gene, is an anti-inflammatory adipokine vital for glucose and lipid regulation. Reduced adiponectin levels and certain <em>ADIPOQ</em> gene variants (e.g., rs266729, rs2241766) have been linked to both NAFLD and CVD progression. This study aims to evaluate the association between <em>ADIPOQ</em> gene expression and early biochemical markers of hepatic and cardiovascular dysfunction.</p> <p><strong>Methods</strong> A case-control study (n = 300) was conducted in Thiruvananthapuram, Kerala, India (2022-2024), analyzing blood samples for fasting blood sugar (FBS), lipid profile, malondialdehyde (MDA), interleukin-6 (IL-6), and <em>ADIPOQ</em> expression (RT-PCR). Statistical analyses included receiver operating characteristic (ROC) curves and quantile regression using Stata 17.0.</p> <p><strong>Results</strong> Cases exhibited significantly elevated FBS, triglycerides (TG), low-density lipoprotein (LDL), MDA, and IL-6, along with reduced high- density lipoprotein (HDL) and adiponectin levels (<em>p</em> < 0.05). ADIPOQ gene expression was markedly downregulated, particularly in individuals with both NAFLD and CVD. A positive correlation was observed between <em>ADIPOQ</em> expression and HDL, and a negative correlation with IL-6. Reduced <em>ADIPOQ</em> expression showed an association with risk in unadjusted analysis, but this association was not statistically significant after adjustment (OR = 0.0220). Nevertheless, ROC analysis indicated potential diagnostic utility.</p> <p><strong>Conclusions</strong> Reduced ADIPOQ expression is significantly associated with early metabolic and inflammatory markers in NAFLD and CVD. These findings highlight the potential utility of ADIPOQ as a biomarker for early detection and targeted prevention strategies in at-risk populations. </p>2026-02-06T00:00:00+07:00Copyright (c) 2026 https://he01.tci-thaijo.org/index.php/CMMJ-MedCMJ/article/view/282093Antimutagenic Potential of Piper sarmentosum Leaf Extracts: Insights from Culinary Preparation2025-10-20T10:05:32+07:00Nichakarn Sanguankaewnichakarn_sanguan@cmu.ac.thBeilin Li beilin_li@cmu.ac.thSirinya Tayasirinya.t@cmu.ac.thRawiwan Wongpoomchaifuncfoodunit@gmail.comOrawan Khantamatorawan.kh@cmu.ac.th<p><strong>Objective</strong> Piper sarmentosum Roxb., a traditional vegetable in Lanna and Thai cuisine, is valued for its flavor but its health-promoting properties after cooking remain unclear. This study investigated the phytochemical profiles, antioxidant capacity, and mutagenicity of its leaf extracts prepared to mimic typical culinary practices.</p> <p><strong>Methods </strong> Three P. sarmentosum extracts were prepared: an ethanolic extract of uncooked leaves (PEE), a hot water extract simulating curry broth (PHWE), and an ethanolic extract of boiled leaf residues representing the cooked leaves in curry (PREE). Their chemical composition, antioxidant activity, and antimutagenic effects were evaluated.</p> <p><strong>Results</strong> The extracts showed distinct phytochemical patterns. PEE and PREE were rich in phenolics and flavonoids, yielding strong antioxidant activity in ABTS and FRAP assays. PHWE contained higher levels of condensed tannins, reflecting the extraction of water-soluble compounds. None of the extracts showed mutagenicity in the Salmonella assay. Notably, PEE and PREE displayed significant antimutagenic activity against aflatoxin B1 (AFB<sub>1</sub>) in Salmonella typhimurium strains TA98 and TA100 with metabolic activation.</p> <p><strong>Conclusions</strong> P. sarmentosum leaves retain considerable antioxidant and antimutagenic potential after cooking, highlighting their value as a safe and functional food ingredient with potential health benefits. </p>2026-02-06T00:00:00+07:00Copyright (c) 2026